{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,5]],"date-time":"2026-07-05T10:27:24Z","timestamp":1783247244524,"version":"3.54.6"},"reference-count":74,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,9,30]],"date-time":"2024-09-30T00:00:00Z","timestamp":1727654400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.ejmech.2024.116902","type":"journal-article","created":{"date-parts":[[2024,9,26]],"date-time":"2024-09-26T06:24:13Z","timestamp":1727331853000},"page":"116902","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Chemical synthesis and enzymatic late-stage diversification of novel pantothenate analogues with antiplasmodial activity"],"prefix":"10.1016","volume":"280","author":[{"given":"Xiangning","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sian","family":"Thistlethwaite","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rohit","family":"Kholiya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacob","family":"Pierscianowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin J.","family":"Saliba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0933-7956","authenticated-orcid":false,"given":"Karine","family":"Auclair","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2024.116902_bib1","series-title":"World Malaria Report","year":"2023"},{"key":"10.1016\/j.ejmech.2024.116902_bib2","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/j.ijpara.2016.05.009","article-title":"Genome-scale comparison of expanded gene families in Plasmodium ovale wallikeri and Plasmodium ovale curtisi with Plasmodium malariae and with other Plasmodium species","volume":"46","author":"Ansari","year":"2016","journal-title":"Int. J. Parasitol."},{"key":"10.1016\/j.ejmech.2024.116902_bib3","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1086\/652240","article-title":"Two nonrecombining sympatric forms of the human malaria parasite Plasmodium ovale occur globally","volume":"201","author":"Sutherland","year":"2010","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.ejmech.2024.116902_bib4","doi-asserted-by":"crossref","first-page":"e338","DOI":"10.1016\/S1473-3099(19)30261-0","article-title":"Antimalarial drug resistance in Africa: the calm before the storm?","volume":"19","author":"Conrad","year":"2019","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.ejmech.2024.116902_bib5","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.3389\/fphar.2019.01526","article-title":"DeepMalaria: artificial intelligence driven discovery of potent antiplasmodials","volume":"10","author":"Keshavarzi Arshadi","year":"2019","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ejmech.2024.116902_bib6","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s12936-016-1675-x","article-title":"New developments in anti-malarial target candidate and product profiles","volume":"16","author":"Burrows","year":"2017","journal-title":"Malar. J."},{"key":"10.1016\/j.ejmech.2024.116902_bib7","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1038\/nrd4573","article-title":"Malaria medicines: a glass half full?","volume":"14","author":"Wells","year":"2015","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ejmech.2024.116902_bib8","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1111\/j.1574-6976.2007.00093.x","article-title":"Coenzyme A biosynthesis: an antimicrobial drug target","volume":"32","author":"Spry","year":"2008","journal-title":"FEMS Microbiol. Rev."},{"key":"10.1016\/j.ejmech.2024.116902_bib9","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0054974","article-title":"Pantothenamides are potent, on-target inhibitors of Plasmodium falciparum growth when serum pantetheinase is inactivated","volume":"8","author":"Spry","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.ejmech.2024.116902_bib10","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1021\/acsinfecdis.7b00024","article-title":"Antiplasmodial mode of action of pantothenamides: pantothenate kinase serves as a metabolic activator not as a target","volume":"3","author":"de Villiers","year":"2017","journal-title":"ACS Infect. Dis."},{"key":"10.1016\/j.ejmech.2024.116902_bib11","doi-asserted-by":"crossref","first-page":"2158","DOI":"10.1038\/s41467-022-29688-5","article-title":"Preclinical characterization and target validation of the antimalarial pantothenamide MMV693183","volume":"13","author":"de Vries","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ejmech.2024.116902_bib12","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.1021\/acsinfecdis.0c00075","article-title":"Toward a stable and potent coenzyme A-targeting antiplasmodial agent: structure-activity relationship studies of N-Phenethyl-alpha-methyl-pantothenamide","volume":"6","author":"Spry","year":"2020","journal-title":"ACS Infect. Dis."},{"key":"10.1016\/j.ejmech.2024.116902_bib13","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1006918","article-title":"Mutations in the pantothenate kinase of Plasmodium falciparum confer diverse sensitivity profiles to antiplasmodial pantothenate analogues","volume":"14","author":"Tjhin","year":"2018","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.ejmech.2024.116902_bib14","doi-asserted-by":"crossref","first-page":"4794","DOI":"10.1128\/AAC.00603-13","article-title":"Combination of pantothenamides with vanin inhibitors as a novel antibiotic strategy against gram-positive bacteria","volume":"57","author":"Jansen","year":"2013","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2024.116902_bib15","doi-asserted-by":"crossref","first-page":"7146","DOI":"10.1128\/AAC.01436-16","article-title":"Triazole substitution of a labile amide bond stabilizes pantothenamides and improves their antiplasmodial potency","volume":"60","author":"Howieson","year":"2016","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2024.116902_bib16","doi-asserted-by":"crossref","first-page":"2677","DOI":"10.1002\/cmdc.201800327","article-title":"Structure-activity relationships of antiplasmodial pantothenamide analogues reveal a new way by which triazoles mimic amide bonds","volume":"13","author":"Guan","year":"2018","journal-title":"ChemMedChem"},{"key":"10.1016\/j.ejmech.2024.116902_bib17","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aas9917","article-title":"Antimalarial pantothenamide metabolites target acetyl-coenzyme A biosynthesis in Plasmodium falciparum","volume":"11","author":"Schalkwijk","year":"2019","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.ejmech.2024.116902_bib18","doi-asserted-by":"crossref","first-page":"4478","DOI":"10.1021\/acs.jmedchem.0c01755","article-title":"Exploring heteroaromatic rings as a replacement for the labile amide of antiplasmodial pantothenamides","volume":"64","author":"Guan","year":"2021","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116902_bib19","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1021\/acsinfecdis.7b00240","article-title":"Developing pantetheinase-resistant pantothenamide antibacterials: structural modification impacts on PanK Interaction and mode of action","volume":"4","author":"Barnard","year":"2018","journal-title":"ACS Infect. Dis."},{"key":"10.1016\/j.ejmech.2024.116902_bib20","doi-asserted-by":"crossref","first-page":"2696","DOI":"10.1016\/j.bmc.2011.02.053","article-title":"Geminal dialkyl derivatives of N-substituted pantothenamides: synthesis and antibacterial activity","volume":"19","author":"Akinnusi","year":"2011","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116902_bib21","doi-asserted-by":"crossref","first-page":"963","DOI":"10.3762\/bjoc.12.95","article-title":"A cross-metathesis approach to novel pantothenamide derivatives","volume":"12","author":"Guan","year":"2016","journal-title":"Beilstein J. Org. Chem."},{"key":"10.1016\/j.ejmech.2024.116902_bib22","doi-asserted-by":"crossref","first-page":"3274","DOI":"10.1016\/j.bmcl.2014.06.013","article-title":"Stereochemical modification of geminal dialkyl substituents on pantothenamides alters antimicrobial activity","volume":"24","author":"Hoegl","year":"2014","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.ejmech.2024.116902_bib23","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1021\/ml400180d","article-title":"Structural modification of pantothenamides counteracts degradation by pantetheinase and improves antiplasmodial activity","volume":"4","author":"de Villiers","year":"2013","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2024.116902_bib24","doi-asserted-by":"crossref","first-page":"3666","DOI":"10.1128\/AAC.04970-14","article-title":"A pantetheinase-resistant pantothenamide with potent, on-target, and selective antiplasmodial activity","volume":"59","author":"Macuamule","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2024.116902_bib25","doi-asserted-by":"crossref","first-page":"16824","DOI":"10.1002\/anie.202014931","article-title":"Enzymatic late-stage modifications: better late than never","volume":"60","author":"Romero","year":"2021","journal-title":"Angew Chem. Int. Ed. Engl."},{"key":"10.1016\/j.ejmech.2024.116902_bib26","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1111\/febs.15185","article-title":"How enzyme promiscuity and horizontal gene transfer contribute to metabolic innovation","volume":"287","author":"Glasner","year":"2020","journal-title":"FEBS J."},{"key":"10.1016\/j.ejmech.2024.116902_bib27","doi-asserted-by":"crossref","first-page":"16890","DOI":"10.1021\/jacs.1c08920","article-title":"Late-stage diversification: a motivating force in organic synthesis","volume":"143","author":"Kim","year":"2021","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.ejmech.2024.116902_bib28","series-title":"Guidelines for the Treatment of Malaria","year":"2015"},{"key":"10.1016\/j.ejmech.2024.116902_bib29","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1046\/j.1365-2125.1999.00044.x","article-title":"Identification of the human cytochrome P450 enzymes involved in the in vitro metabolism of artemisinin","volume":"48","author":"Svensson","year":"1999","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.ejmech.2024.116902_bib30","doi-asserted-by":"crossref","first-page":"2945","DOI":"10.1021\/jm030571c","article-title":"A medicinal chemistry perspective on artemisinin and related endoperoxides","volume":"47","author":"O'Neill","year":"2004","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116902_bib31","doi-asserted-by":"crossref","first-page":"2694","DOI":"10.1021\/jm0310333","article-title":"Fluoroartemisinin: trifluoromethyl analogues of artemether and artesunate","volume":"47","author":"Magueur","year":"2004","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116902_bib32","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1021\/acscentsci.9b00916","article-title":"Late-stage diversification of natural products","volume":"6","author":"Hong","year":"2020","journal-title":"ACS Cent. Sci."},{"key":"10.1016\/j.ejmech.2024.116902_bib33","doi-asserted-by":"crossref","first-page":"5845","DOI":"10.1021\/jm4017625","article-title":"Rings in drugs","volume":"57","author":"Taylor","year":"2014","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116902_bib34","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1016\/S0140-6736(04)15836-4","article-title":"A large focus of naturally acquired Plasmodium knowlesi infections in human beings","volume":"363","author":"Singh","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.ejmech.2024.116902_bib35","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1186\/1475-2875-13-390","article-title":"Changing epidemiology of malaria in Sabah, Malaysia: increasing incidence of Plasmodium knowlesi","volume":"13","author":"William","year":"2014","journal-title":"Malar. J."},{"key":"10.1016\/j.ejmech.2024.116902_bib36","doi-asserted-by":"crossref","DOI":"10.3390\/ijms222111380","article-title":"A promiscuous bacterial P450: the unparalleled diversity of BM3 in pharmaceutical metabolism","volume":"22","author":"Thistlethwaite","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejmech.2024.116902_bib37","series-title":"Four Billion Years: an Essay on the Evolution of Genes and Organisms","author":"Loomis","year":"1988"},{"key":"10.1016\/j.ejmech.2024.116902_bib38","doi-asserted-by":"crossref","DOI":"10.1098\/rstb.2012.0434","article-title":"Unusual properties of the cytochrome P450 superfamily","volume":"368","author":"Lamb","year":"2013","journal-title":"Philos. Trans. R. Soc. Lond. B Biol. Sci."},{"key":"10.1016\/j.ejmech.2024.116902_bib39","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/0014-5793(94)80609-8","article-title":"Structural and enzymological analysis of the interaction of isolated domains of cytochrome P-450 BM3","volume":"343","author":"Munro","year":"1994","journal-title":"FEBS Lett."},{"key":"10.1016\/j.ejmech.2024.116902_bib40","doi-asserted-by":"crossref","first-page":"11723","DOI":"10.1002\/chem.200900643","article-title":"A panel of cytochrome P450 BM3 variants to produce drug metabolites and diversify lead compounds","volume":"15","author":"Sawayama","year":"2009","journal-title":"Chemistry"},{"key":"10.1016\/j.ejmech.2024.116902_bib41","doi-asserted-by":"crossref","first-page":"15901","DOI":"10.3390\/ijms131215901","article-title":"Optimization of the bacterial cytochrome P450 BM3 system for the production of human drug metabolites","volume":"13","author":"Di Nardo","year":"2012","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejmech.2024.116902_bib42","doi-asserted-by":"crossref","first-page":"25387","DOI":"10.1074\/jbc.M113.479717","article-title":"Key mutations alter the cytochrome P450 BM3 conformational landscape and remove inherent substrate bias","volume":"288","author":"Butler","year":"2013","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejmech.2024.116902_bib43","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1042\/BJ20140030","article-title":"Human P450-like oxidation of diverse proton pump inhibitor drugs by 'gatekeeper' mutants of flavocytochrome P450 BM3","volume":"460","author":"Butler","year":"2014","journal-title":"Biochem. J."},{"key":"10.1016\/j.ejmech.2024.116902_bib44","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1038\/s41598-018-37330-y","article-title":"Novel insights into P450 BM3 interactions with FDA-approved antifungal azole drugs","volume":"9","author":"Jeffreys","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejmech.2024.116902_bib45","series-title":"Dosage Form Design Considerations","first-page":"637","article-title":"Four stages of pharmaceutical product development: Preformulation, prototype development and scale-up, biological aspects, and commercialization","author":"Amarji","year":"2018"},{"key":"10.1016\/j.ejmech.2024.116902_bib46","doi-asserted-by":"crossref","first-page":"3626","DOI":"10.1021\/acs.jmedchem.8b00116","article-title":"Lead diversification at the nanomole scale using liver microsomes and quantitative nuclear magnetic resonance spectroscopy: application to phosphodiesterase 2 inhibitors","volume":"61","author":"Obach","year":"2018","journal-title":"J. Med. Chem."},{"issue":"Pt 2","key":"10.1016\/j.ejmech.2024.116902_bib47","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1042\/bj3390371","article-title":"Roles of key active-site residues in flavocytochrome P450 BM3","volume":"339","author":"Noble","year":"1999","journal-title":"Biochem. J."},{"key":"10.1016\/j.ejmech.2024.116902_bib48","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1039\/C1CS15192D","article-title":"P450(BM3) (CYP102A1): connecting the dots","volume":"41","author":"Whitehouse","year":"2012","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.ejmech.2024.116902_bib49","doi-asserted-by":"crossref","first-page":"7721","DOI":"10.1021\/ac300952r","article-title":"Small-molecule-based affinity chromatography method for antibody purification via nucleotide binding site targeting","volume":"84","author":"Alves","year":"2012","journal-title":"Anal. Chem."},{"key":"10.1016\/j.ejmech.2024.116902_bib50","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.1016\/j.chroma.2010.10.070","article-title":"Kinetic studies of drug-protein interactions by using peak profiling and high-performance affinity chromatography: examination of multi-site interactions of drugs with human serum albumin columns","volume":"1218","author":"Tong","year":"2011","journal-title":"J. Chromatogr. A"},{"key":"10.1016\/j.ejmech.2024.116902_bib51","doi-asserted-by":"crossref","first-page":"6924","DOI":"10.1039\/c3an01312j","article-title":"Structural evaluation of GM1-related carbohydrate-cholera toxin interactions through surface plasmon resonance kinetic analysis","volume":"138","author":"Seo","year":"2013","journal-title":"Analyst"},{"key":"10.1016\/j.ejmech.2024.116902_bib52","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.jpha.2018.05.001","article-title":"Overview of the detection methods for equilibrium dissociation constant KD of drug-receptor interaction","volume":"8","author":"Ma","year":"2018","journal-title":"J Pharm Anal"},{"key":"10.1016\/j.ejmech.2024.116902_bib53","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.abb.2010.12.008","article-title":"Spectroscopic features of cytochrome P450 reaction intermediates","volume":"507","author":"Luthra","year":"2011","journal-title":"Arch. Biochem. Biophys."},{"issue":"Pt 2","key":"10.1016\/j.ejmech.2024.116902_bib54","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1042\/bj2880503","article-title":"Domains of the catalytically self-sufficient cytochrome P-450 BM-3. Genetic construction, overexpression, purification and spectroscopic characterization","volume":"288","author":"Miles","year":"1992","journal-title":"Biochem. J."},{"key":"10.1016\/j.ejmech.2024.116902_bib55","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1074\/jbc.M607949200","article-title":"Structural and spectroscopic characterization of P450 BM3 mutants with unprecedented P450 heme iron ligand sets. New heme ligation states influence conformational equilibria in P450 BM3","volume":"282","author":"Girvan","year":"2007","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejmech.2024.116902_bib56","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.bbapap.2017.06.021","article-title":"Spectroscopic studies of the cytochrome P450 reaction mechanisms","volume":"1866","author":"Mak","year":"2018","journal-title":"Biochim Biophys Acta Proteins Proteom"},{"key":"10.1016\/j.ejmech.2024.116902_bib57","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-14074-9","article-title":"The antimalarial activity of the pantothenamide \u03b1-PanAm is via inhibition of pantothenate phosphorylation","volume":"7","author":"Chiu","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejmech.2024.116902_bib58","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1124\/dmd.32.3.333","article-title":"In vitro sulfoxidation of thioether compounds by human cytochrome P450 and flavin-containing monooxygenase isoforms with particular reference to the CYP2C subfamily","volume":"32","author":"Usmani","year":"2004","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.ejmech.2024.116902_bib59","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1002\/med.21474","article-title":"Strategies to diversify natural products for drug discovery","volume":"38","author":"Li","year":"2018","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.ejmech.2024.116902_bib60","doi-asserted-by":"crossref","first-page":"2226","DOI":"10.1002\/cctc.201801829","article-title":"P450 monooxygenases enable rapid late-stage diversification of natural products via C-H bond activation","volume":"11","author":"Fessner","year":"2019","journal-title":"ChemCatChem"},{"key":"10.1016\/j.ejmech.2024.116902_bib61","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/j.tibs.2020.03.004","article-title":"Natural compounds as pharmaceuticals: the key role of cytochromes P450 reactivity","volume":"45","author":"Di Nardo","year":"2020","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.ejmech.2024.116902_bib62","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1021\/acs.jnatprod.9b01285","article-title":"Natural products as sources of new drugs over the nearly four decades from 01\/1981 to 09\/2019","volume":"83","author":"Newman","year":"2020","journal-title":"J Nat Prod"},{"key":"10.1016\/j.ejmech.2024.116902_bib63","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/S0021-9258(17)49939-X","article-title":"Engineering cytochrome P450 enzyme systems for biomedical and biotechnological applications","volume":"295","author":"Li","year":"2020","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejmech.2024.116902_bib64","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1038\/nrd.2018.217","article-title":"Expanding the medicinal chemistry synthetic toolbox","volume":"17","author":"Bostrom","year":"2018","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ejmech.2024.116902_bib65","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1021\/acsmedchemlett.0c00202","article-title":"Biotransformation: impact and application of metabolism in drug discovery","volume":"11","author":"Shanu-Wilson","year":"2020","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2024.116902_bib66","doi-asserted-by":"crossref","first-page":"7810","DOI":"10.1021\/acs.jpca.5b01346","article-title":"Active thermochemical tables: sequential bond dissociation enthalpies of methane, ethane, and methanol and the related thermochemistry","volume":"119","author":"Ruscic","year":"2015","journal-title":"J. Phys. Chem. A"},{"key":"10.1016\/j.ejmech.2024.116902_bib67","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/s00018-007-6362-1","article-title":"Enzymatic hydroxylation of aromatic compounds","volume":"64","author":"Ullrich","year":"2007","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.ejmech.2024.116902_bib68","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1021\/tx015574b","article-title":"Biotransformation reactions of five-membered aromatic heterocyclic rings","volume":"15","author":"Dalvie","year":"2002","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.ejmech.2024.116902_bib69","doi-asserted-by":"crossref","DOI":"10.1016\/j.tmaid.2023.102684","article-title":"Artemisinin resistance-associated gene mutations in Plasmodium falciparum: a case study of severe malaria from Mozambique","volume":"57","author":"Casanova","year":"2024","journal-title":"Travel Med Infect Dis"},{"key":"10.1016\/j.ejmech.2024.116902_bib70","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1126\/science.781840","article-title":"Human malaria parasites in continuous culture","volume":"193","author":"Trager","year":"1976","journal-title":"Science"},{"key":"10.1016\/j.ejmech.2024.116902_bib71","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.molbiopara.2009.09.005","article-title":"Plasmodium falciparum culture: the benefits of shaking","volume":"169","author":"Allen","year":"2010","journal-title":"Mol. Biochem. Parasitol."},{"key":"10.1016\/j.ejmech.2024.116902_bib72","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1177\/1087057103256465","article-title":"A simple technique for reducing edge effect in cell-based assays","volume":"8","author":"Lundholt","year":"2003","journal-title":"J. Biomol. Screen"},{"key":"10.1016\/j.ejmech.2024.116902_bib73","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.1128\/AAC.01607-06","article-title":"Assessment and continued validation of the malaria SYBR green I-based fluorescence assay for use in malaria drug screening","volume":"51","author":"Johnson","year":"2007","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2024.116902_bib74","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/0005-2744(69)90420-3","article-title":"Kinetics of the reversible inhibition of enzyme-catalysed reactions by tight-binding inhibitors","volume":"185","author":"Morrison","year":"1969","journal-title":"Biochim. Biophys. Acta"}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523424007839?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523424007839?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,21]],"date-time":"2024-11-21T06:21:10Z","timestamp":1732170070000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523424007839"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":74,"alternative-id":["S0223523424007839"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2024.116902","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Chemical synthesis and enzymatic late-stage diversification of novel pantothenate analogues with antiplasmodial activity","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2024.116902","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"116902"}}